Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Mild cognitive impairment (MCI) and cognitive impairment, no dementia (CIND) are controversial emerging terms that encompass the clinical state between elderly normal cognition and dementia. This article reviews recent work on the classification of MCI and CIND, their prognosis, and diagnostic approaches and presents evidence‐based recommendations approved at the meeting of the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD3) held in Montreal in March, 2006. New short tools such as the Montreal Cognitive Assessment are making it easier for family physicians to confidently attach the label of MCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Self-citationA New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
Six-item screener to identify cognitive impairment among potential subjects for clinical research
Callahan, C. M., Unverzagt, F. W., Hui, S. L., Perkins, A. J., & Hendrie, H. C. (2002) · Medical Care · doi:10.1097/00005650-200209000-00007 · Cited by 1,499
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972
Research works printed but not linked: 111
- 10.1016/0197-2456(95)00134-4 · DOI · Paper page
- 10.1016/0895-4356(90)90073-X · DOI · Paper page
- CSHA, 2000, The incidence of dementia in Canada: the Canadian Study of Health and Aging Working Group, Neurology, 55, 66, 10.1212/WNL.55.1.66 · DOI · Paper page
- McKann G., 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS‐ADRDA work group under the auspices of the Department of Health Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- 10.1080/87565648609540348 · DOI · Paper page
- 10.1080/87565648909540440 · DOI · Paper page
- 10.1111/j.1532-5415.1995.tb05565.x · DOI · Paper page
- 10.1080/13825589608256617 · DOI
- Salthouse T.A., 1991, Theoretical perspectives on cognitive aging, 438
- 10.1212/WNL.56.11.1533 · DOI · Paper page
- 10.1093/geronb/51B.4.P217 · DOI · Paper page
- 10.1076/clin.14.4.504.7200 · DOI
- 10.1016/S0140-6736(97)01007-6 · DOI · Paper page
- 10.1001/archneur.1995.00540300086018 · DOI · Paper page
- 10.1001/archneur.60.4.577 · DOI · Paper page
- 10.1159/000071189 · DOI · Paper page
- 10.1176/appi.ajp.159.3.436 · DOI · Paper page
- 10.1111/j.1532-5415.1985.tb07109.x · DOI · Paper page
- Reisberg B., 1988, Global Deterioration Scale (GDS), Psychopharmacol Bull, 24, 661
- 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5 · DOI · Paper page
- 10.1002/gps.930070705 · DOI · Paper page
- 10.1111/j.1532-5415.1993.tb06448.x · DOI · Paper page
- 10.1017/S1041610294001626 · doi:10.1017/s1041610294001626
- Smith A.D., 1996, Use of structural imaging to study the progression of Alzheimer's disease, Br Med Bull, 52, 3, 10.1093/oxfordjournals.bmb.a011568 · DOI · Paper page
- 10.1001/archneur.56.3.303 · DOI · Paper page
- 10.1001/jama.1995.03520400044042 · DOI · Paper page
- 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
- 10.1212/01.WNL.0000132523.27540.81 · DOI · Paper page
- Lopez O., 2002, Risk factors for mild cognitive impairment in a population study, Neurology, 58, A238
- Chertkow H., 1998, Mild memory loss in the elderly: can we predict development in dementia?, Can J Neurol Sci, 25, 1
- 10.1159/000078504 · DOI · Paper page
- H.M.Chertkow A.Duong N.Philips H.Bergman L.Babins N.KelnerMild cognitive impairment the danger of basing the diagnosis on published normative groups (P3‐072) Paper presented at ICAD‐Alzheimer's Association 10th International Conference on Alzheimer's Disease and Related Disorders2006 Madrid Spain · doi:10.1016/j.jalz.2006.05.1339
- 10.1136/jnnp.2005.085332 · DOI · Paper page
- Grundman M., 1996, ADSC Cooperative Study: rate of dementia of the Alzheimer type (DAT) in subjects with mild cognitive impairment, Neurology, 46, A403
- 10.1212/01.wnl.0000238517.59286.c5 · DOI · Paper page
- 10.1192/bjp.168.4.470 · DOI
- 10.1001/archneur.58.3.397 · DOI · Paper page
- 10.1212/01.WNL.0000080366.90234.7F · DOI · Paper page
- 10.1002/(SICI)1099-1166(200005)15:5<434::AID-GPS137>3.0.CO;2-2 · DOI
- 10.1212/WNL.56.1.37 · DOI · Paper page
- 10.1016/S0140-6736(99)06155-3 · DOI · Paper page
- Chertkow H.M., 1998, Standard neuropsychological tests do not predict development of Alzheimer's Disease in indivduals with “Age‐associated Cognitive Decline”, Can J Neurol Sci, 25, S27
- Craik F., 1994, Memory changes in normal aging, Curr Dir Psychol Sci, 3, 1558, 10.1111/1467-8721.ep10770653 · DOI · Paper page
- 10.1002/gps.477 · DOI · Paper page
- 10.1111/j.1532-5415.2000.tb04992.x · DOI · Paper page
- 10.1159/000051284 · DOI · Paper page
- 10.1001/jama.281.15.1401 · DOI · Paper page
- 10.1001/archneur.57.5.675 · DOI · Paper page
- 10.1212/01.WNL.0000089238.07771.C7 · DOI · Paper page
- Hsiung G.‐Y., 2002, An analysis of vascular risk factors and ApoE genotype in subtypes of dementia in the ACCORD study, Neurology, 58, A107
- 10.1001/archneur.55.8.1065 · DOI · Paper page
- 10.1212/WNL.54.7.1492 · DOI · Paper page
- 10.1037/0882-7974.13.1.80 · doi:10.1037/0882-7974.13.1.80
- 10.1159/000017092 · DOI · Paper page
- Corrada M., 2002, Plasma total cholesterol, LDL, HDL levels and the risk of Alzheimer disease: the Baltimore Longitudinal Study of Aging, Neurology, 58, A106
- Yaffe K., 2002, Inflammatory markers and cognitive decline in well‐functioning elders: the Health ABC Study, Neurology, 58, A106
- Fox N.C., 2000, Increased rates of atrophy in early and preclinical AD: studies with registration of serial MRI, Neurobiol Aging, 21, S74, 10.1016/S0197-4580(00)82552-X · doi:10.1016/s0197-4580(00)82552-x
- M.J.deLeon A.Convit.Longitudinal measures of hippocampal formation pathology and CSF measures of phospho‐tau and amyloid beta: early markers for Alzheimer disease Paper presented at Seventh International Geneva/Springfield symposium on advances in Alzheimer Therapy2002 Geneva Switzerland
- McKelvey R., 1999, Lack of prognostic significance of SPECT abnormalities in non‐demented elderly subjects with memory loss, Can J Neurol Sci, 26, 23
- 10.1212/WNL.55.2.210 · DOI · Paper page
- A.Nordberg.PET activation in MCI and AD patients Paper presented at Seventh Annual Springfield/Geneva symposium on advances in Alzheimer Therapy2002 Geneva Switzerland
- L.Backman.The cognitive transition from normal aging to AD Paper presented at the Seventh Springfield/Geneva symposium on advances in Alzheimer Therapy2002 Geneva Switzerland
- 10.1001/archneur.58.3.411 · DOI · Paper page
- 10.1001/archneur.1996.00550050053023 · DOI · Paper page
- 10.1111/j.1532-5415.1997.tb00947.x · DOI · Paper page
- 10.1176/appi.ajp.157.9.1399 · DOI · Paper page
- 10.1017/S1355617701755105 · DOI · Paper page
- 10.1212/WNL.53.7.1480 · DOI · Paper page
- 10.1212/WNL.54.6.1297 · DOI · Paper page
- 10.1016/S0304-3940(99)00617-5 · DOI · Paper page
- 10.1212/01.WNL.0000147470.58328.50 · DOI · Paper page
- 10.1097/01.wad.0000126613.05674.0c · DOI · Paper page
- 10.1016/j.cger.2003.10.001 · DOI
- 10.1212/WNL.59.2.198 · DOI · Paper page
- 10.1001/archneur.63.1.15 · DOI
- 10.1007/s11910-003-0020-2 · DOI
- Ritchie K., 2004, Mild cognitive impairment: an epidemiological perspective, Dialogues in Clinical Neuroscience, 6, 401, 10.31887/DCNS.2004.6.4/kritchie · DOI · Paper page
- 10.1212/01.WNL.0000034176.07159.F8 · DOI · Paper page
- 10.1007/978-3-7091-7508-8_4 · DOI
- H.Chertkow.Five year follow‐up of mild cognitive impairment predictors of progression—the 8th International Conference on Alzheimer's Disease and Related Disorders. Stockholm Sweden July2002
- 10.1002/gps.1049 · DOI · Paper page
- Petersen R.C., 1999, Mild cognitive impairment: clinical characterization and outcome—correction, Arch Neurol, 56, 6, 10.1001/archneur.56.3.303 · DOI · Paper page
- 10.1046/j.1440-1614.2002.00972.x · DOI · Paper page
- 10.1097/00019442-200508000-00003 · DOI · Paper page
- 10.1016/S1474-4422(03)00262-X · DOI · Paper page
- 10.1212/01.WNL.0000134664.80320.92 · DOI · Paper page
- Jelic V., 2003, Treatment of mild cognitive impairment: rationale, present and future strategies, Acta Neurol Scand Suppl, 179, 83, 10.1034/j.1600-0404.107.s179.12.x · DOI
- 10.1002/gps.1042 · DOI · Paper page
- 10.1007/s00415-005-0597-2 · DOI
- 10.1159/000079198 · DOI
- 10.1177/070674370505000110 · DOI
- Xu G., 2004, Cross‐cultural comparison of mild cognitive impairment between China and USA, Curr Alzheimer Res, 1, 55, 10.2174/1567205043480564 · DOI
- 10.1080/1360786031000120741 · DOI
- 10.1001/archneur.60.12.1777 · DOI · Paper page
- 10.1073/pnas.0501157102 · DOI · Paper page
- 10.1111/j.1532-5415.2005.53269.x · DOI · Paper page
- 10.1212/WNL.62.4.556 · DOI · Paper page
- 10.1212/WNL.59.7.1042 · DOI · Paper page
- 10.1034/j.1600-0404.2002.01225.x · DOI · Paper page
- 10.1006/nimg.2001.0992 · DOI
- 10.1017/S0033291703007839 · DOI · Paper page
- 10.1093/brain/awg236 · DOI · Paper page
- Farlow M.R., 2004, Impact of APOE in mild cognitive impairment, Neurology, 63, 1898, 10.1212/01.WNL.0000144279.21502.B7 · DOI · Paper page
- 10.1212/01.WNL.0000118301.92105.EE · DOI · Paper page
- 10.1212/01.WNL.0000144281.38555.E3 · DOI · Paper page
- 10.1080/13554790490896820 · DOI · Paper page
- 10.1001/archneur.62.6.975 · DOI · Paper page
- Geslani D.M., 2005, Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease, Dement Geriatr Cogn Disord, 19, 383, 10.1159/000084709 · DOI · Paper page
- 10.1159/000082351 · DOI · Paper page
- 10.1111/j.1532-5415.2005.53566.x · DOI · Paper page
- 10.1136/jnnp.2004.047720 · DOI · Paper page
Cited by
Blondell, S. J., Hammersley-Mather, R., & Veerman, J. L. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-510 · Cited by 928
“Neuroimaging of people with MCI has shown early structural changes that are in keeping with what would be expected of AD sufferers [10].”
BackgroundInfluentialSpectral-Domain OCT Measurements in Alzheimer’s Disease
Chan, V. T. T., Sun, Z., Tang, S., Chen, L. J., Wong, A., Tham, C. C., Wong, T. Y., Chen, C., Ikram, M. K., Whitson, H. E., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.08.009 · Cited by 360
Krikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., & Joseph, J. A. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114509992364 · Cited by 353
Ahmadi-Abhari, S., Guzman-Castillo, M., Bandosz, P., Shipley, M. J., Muniz-Terrera, G., Singh-Manoux, A., Kivimäki, M., Steptoe, A., Capewell, S., O’Flaherty, M., et al. (2017) · BMJ · doi:10.1136/bmj.j2856 · Cited by 301
Chen, Y., Bandosz, P., Stoye, G., Liu, Y., Wu, Y., Lobanov-Rostovsky, S., French, E., Kivimaki, M., Livingston, G., Liao, J., et al. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00214-1 · Cited by 96
“23 To avoid the effect of transient cognitive decline, resulting from delirium or other mental disorders, if the participant improved by 1 SD or more on cognitive tests in the con secutive wave, they were considered to not have cognitive impairment.”
Background
Metadata
- Authors
- Chertkow, H., Nasreddine, Z., Joanette, Y., Drolet, V., Kirk, J., Massoud, F., Belleville, S., & Bergman, H.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2007-10
- Volume
- 3
- Issue
- 4
- Pages
- 266-282
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W1972349970
- Cited by
- 116
- References
- 24
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Canadian Institutes of Health Research (MOP‐15006)
- Alzheimer Society
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis. https://app.cochat.ai/papers/10.1016/j.jalz.2007.07.013
- The paper
- Chertkow, H., Nasreddine, Z., Joanette, Y., Drolet, V., Kirk, J., Massoud, F., Belleville, S., & Bergman, H. (2007). Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2007.07.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.